BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  clinic: 35732, phase: 14647, trial: 20182     

HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
Vancouver, BC--(Marketwire) - Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product...

Pharmaceutical Online:  Jul 3 2009 10:36AM
Matching: clinic phase trial
Find similar documents
HTML
100%
Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carbopla
CALGARY, July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.

announced today that patient enrolment has been completed in the Phase II component of a Phase I/II U.K.

trial of REOLYSIN combined with paclitaxel...

Kait 8:  Jul 3 2009 4:30AM
Matching: clinic phase trial
Find similar documents
HTML
100%
India needs to allow phase I trials of new drugs developed abroad: Dr Nadig
Indian regulatory authorities should allow to conduct phase 1 study for compounds developed abroad if its expertise and skill to invent new drugs is to be recognized internationally according to Dr Ramanand Nadig, president and deputy...
PharmaBiz:  Jul 3 2009 4:18AM
Matching: clinic phase trial
Find similar documents
HTML
100%
Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carbopla
CALGARY, July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.

announced today that patient enrolment has been completed in the Phase II component of a Phase I/II U.K.

trial of REOLYSIN combined with paclitaxel...

KSLA:  Jul 3 2009 12:33AM
Matching: clinic phase trial
Find similar documents
HTML
100%
Oncolytics Biotech completes enrollment in head and neck cancer trial
(Datamonitor via COMTEX) -- ONCY | Quote | Chart | News | PowerRating -- Oncolytics Biotech, a Canadian biopharmaceutical company, has completed patient enrollment in the Phase II component of a Phase I/II UK trial of...
TradingMarkets:  Jul 3 2009 3:00PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Phase Forward signs new deal with GSK
Data management specialist Phase Forward has landed a multi-million dollar clinical trial services contract with GSK.

Under yesterdays agreement, Phase Forward will provide GlaxoSmithKline (GSK) with licensing and...

Outsourcing Pharma:  Jul 3 2009 3:54AM
Matching: clinic phase trial
Find similar documents
HTML
100%
Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
- Completion of Phase I Paves Way for Expanding Bavituximab Cancer Program - - Inclusion of Patients with Diverse Advanced Cancers Along with Promising Interim Phase II Data Suggest Bavituximab Could Have Broad Anti-Cancer...
Pharma Live:  Jul 2 2009 10:43AM
Matching: clinic phase trial
Find similar documents
HTML
100%
Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
- Completion of Phase I Paves Way for Expanding Bavituximab Cancer Program - - Inclusion of Patients with Diverse Advanced Cancers Along with Promising Interim Phase II Data Suggest Bavituximab Could Have Broad Anti-Cancer...
SmartBrief:  Jul 2 2009 4:28AM
Matching: clinic phase trial
Find similar documents
HTML
100%
Phase Forward Customer GlaxoSmithKline Signs Multi-Year Agreements
- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that GlaxoSmithKline (GSK) has signed multi-year, multi-million dollar contracts covering...
Atlas Venture:  Jul 2 2009 8:09PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carbopla
CALGARY , July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.

(TSX: ONC, NASDAQ: ONCY) announced today that patient enrolment has been completed in the Phase II component of a Phase I/II U.K.

trial of REOLYSIN...

NewsBlaze:  Jul 2 2009 3:54PM
Matching: clinic phase trial
Find similar documents
HTML
100%
GlaxoSmithKline signs contract for Phase Forward clinical trials software
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, has announced that GlaxoSmithKline (GSK) has signed multi-year, multi-million dollar contracts covering...
MTB Europe:  Jul 2 2009 10:19PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
-(T-Net)--Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being...

BC Technology:  Jul 2 2009 9:06PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a...

Pharma Live:  Jul 2 2009 9:04PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
VANCOUVER, BRITISH COLUMBIA, Jul 02 (MARKET WIRE) -- Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi...

Reuters:  Jul 2 2009 1:39PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a...

Genetic Engineering News:  Jul 2 2009 1:26PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 07/02/09 -- Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead...

PR inside:  Jul 2 2009 12:56PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a...

NewsBlaze:  Jul 2 2009 12:55PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
(Marketwire via COMTEX) -- TKMRF | Quote | Chart | News | PowerRating -- Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP,...

TradingMarkets:  Jul 2 2009 12:54PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
VANCOUVER (Marketwire) - Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is...

Canadian Business Magazine:  Jul 2 2009 12:51PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a...

Market Wire:  Jul 2 2009 12:51PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a...

Globe Investor:  Jul 2 2009 12:47PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
Tekmira Pharmaceuticals Corporation (TSX:TKM - News) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed...

Yahoo! Canada:  Jul 2 2009 12:45PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a...

Street Insider:  Jul 2 2009 12:43PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.

ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a...

StockHouse USA:  Jul 2 2009 12:38PM
Matching: clinic phase trial
Find similar documents
HTML
100%
Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R)
Oncolytics Biotech(R) Inc.

Completes Patient Enrolment in U.K.

Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial CALGARY, July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.

(TSX: ONC, NASDAQ: ONCY...

Reuters:  Jul 2 2009 12:55PM
Matching: clinic phase trial
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.